Elbe Kliniken Stade-Buxtehude

Hospital


Location: Buxtehude / Stade, Germany (DE) DE

ISNI: 0000000405581967

ROR: https://ror.org/04psvb108

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Effectiveness and Safety of Dabrafenib and Trametinib in Patients with BRAFV600 Mutated Metastatic Melanoma in the Real-World Setting - Final Results of the Non-Interventional COMBI-r Study (2022) Berking C, Livingstone E, Weichenthal M, Leiter-Stoeppke U, Remy J, Eigentler T, Mohr P, et al. Conference contribution Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity (2022) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Wahrnehmung der Corona-Pandemie durch Neurodermitispatienten – Ergebnisse aus dem Neurodermitisregister TREATgermany (2022) Helmert C, Siegels D, Haufe E, Abraham S, Heratizadeh A, Kleinheinz A, Harder I, et al. Journal article Perception of the coronavirus pandemic by patients with atopic dermatitis - Results from the TREATgermany registry (2021) Helmert C, Siegels D, Haufe E, Abraham S, Heratizadeh A, Kleinheinz A, Harder I, et al. Journal article IMMUNE PROFILING OF PATIENTS WITH ADVANCED SOLID TUMORS TREATED WITH INTRATUMORALLY ADMINISTERED CV8102 AS A SINGLE-AGENT OR IN COMBINATION WITH ANTI-PD-1 ANTIBODIES IN PHASE I CLINICAL TRIAL (2021) Codo P, Eigentler T, Heinzerling L, Krauss J, Weishaupt C, Ochsenreither S, Lebbe C, et al. Conference contribution Assessment of the Severity of Atopic Dermatitis by Physicians and Patients depending on Gender: Results from the German Atopic Dermatitis Registry TREATgermany (2021) Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al. Conference contribution Fatigue and Atopic Dermatitis: Results from the German Atopic Dermatitis Registery TREATgermany (2021) Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al. Conference contribution Status report on the atopic dermatitis registry TREATgermany Statusbericht zum Neurodermitisregister TREATgermany (2021) Siegels D, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Abraham S, et al. Journal article, Review article
1 2 3 4 5 ... 9